Actos To Get Bladder Cancer Warnings In Europe And A Chance At A Rebound
This article was originally published in The Pink Sheet Daily
Executive Summary
EU's top scientific advisory panel says Takeda's diabetes drug should have new contraindications and warnings about bladder cancer added to its prescribing information.